tiprankstipranks
Kintara Therapeutics (KTRA)
NASDAQ:KTRA
Holding KTRA?
Track your performance easily

Kintara Therapeutics (KTRA) Ownership - Who Owns Kintara Therapeutics?

799 Followers

Kintara Therapeutics (KTRA) Ownership Overview

0.10%0.21%0.02%99.67%
0.21% Other Institutional Investors
0.02% ETFs
99.67% Public Companies and
Individual Investors
The ownership structure of Kintara Therapeutics (KTRA) stock is a mix of institutional, retail, and individual investors. Approximately 0.33% of the company’s stock is owned by Institutional Investors, and 99.67% is owned by Public Companies and Individual Investors.
The ownership structure of Kintara Therapeutics (KTRA) stock is a mix of institutional, retail, and individual investors. Approximately 0.23% of the company’s stock is owned by Institutional Investors, 0.10% is owned by Insiders, and 99.67% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
42,803Institution0.08%
12,455Institution0.02%
12,455Institution0.02%

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
42,803Institution0.08%
12,455Institution0.02%

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Kintara Therapeutics (KTRA)?
Currently, no data Available
What percentage of Kintara Therapeutics (KTRA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.21% of Kintara Therapeutics (KTRA) stock is held by institutional investors.
    What percentage of Kintara Therapeutics (KTRA) stock is held by retail investors?
    According to the latest TipRanks data, approximately 99.67% of Kintara Therapeutics (KTRA) stock is held by retail investors.
      Who owns the most shares of Kintara Therapeutics (KTRA)?
      Fidelity Concord Street Trust owns the most shares of Kintara Therapeutics (KTRA).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis